By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



35 Bezalel Street
Paz Tower, 17th Floor
Ramat Gan    52521  Israel
Phone: 03-7534100 Fax: 03-7515134



Company News
Obecure Achieves Successful Results in Its Proof of Concept Clinical Study Evaluating the Ability of Histalean(TM) to Mitigate Weight Gain Associated With Olanzapine 6/15/2009 9:47:44 AM
Obecure Completes Patient Enrollment for Its Confirmatory Phase IIb Trial with HistaleanTM in Obesity 1/20/2009 11:59:37 AM
Obecure Recruits First Patient in Phase II Obesity Study in Pre-Menopause Women 9/8/2008 8:59:34 AM
Obecure Signs Strategic Agreement with Farmaceutici-Formenti of the Grunenthal Group for Manufacturing and Supply of Betahistine in Europe 4/9/2008 8:23:26 AM
Obecure Phase II Trial Shows Positive Results For Histalean(TM) In Obese Women Under 50 8/30/2007 7:38:00 AM
Obecure Completes Treatment of Patients in Phase II Obesity Trial 6/25/2007 1:32:00 PM
Obecure Initiates Phase II Study to Examine Effect of OBE101 on Plasma Lipids in Patients Treated With Simvastatin 5/16/2007 12:20:56 PM
Obecure Completes Patient Enrollment for Phase II Obesity Trial 4/11/2007 12:35:51 PM
Obecure Initiates Phase II Weight Gain Prevention Study for Patients Taking Zyprexa 3/13/2007 1:24:37 PM
Obecure Recruits First Patient In Phase II Obesity Study 1/24/2007 11:33:48 AM